Paolo Dallaglio

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jonathan P. Piccini, Valeria Caso, Stuart J. Connolly et al. · The Lancet · 2022 · 296 citations · Full text

Thrombosis, Dose-finding Phase 2, Cardiovascular Disease +10

Improved Risk Stratification for Ventricular Arrhythmias and Sudden Death in Patients With Nonischemic Dilated Cardiomyopathy

Andrea Di Marco, Pamela Frances Brown, Joshua Bradley et al. · Journal of the American College of Cardiology · 2021 · 165 citations

Ventricular Arrhythmias, Heart Failure, Cardiomyopathy +11

Impact of a Chronic Total Occlusion in an Infarct‐Related Artery on the Long‐Term Outcome of Ventricular Tachycardia Ablation

Andrea Di Marco, Gabriele Paglino, Teresa Olóriz et al. · Journal of Cardiovascular Electrophysiology · 2015 · 64 citations

Beneficial effect of corticosteroids in preventing mortality in patients receiving tocilizumab to treat severe COVID-19 illness

Manuel Rubio‐Rivas, Mar Ronda, Ariadna Padullés et al. · International Journal of Infectious Diseases · 2020 · 43 citations · Full text

Long Covid, Beneficial Effect, Immunology +5

Chronic total occlusion of an infarct-related artery: a new predictor of ventricular arrhythmias in primary prevention implantable cardioverter defibrillator patients

Andrea Di Marco, Ignasi Anguera, Luis Teruel et al. · EP Europace · 2016 · 37 citations · Full text